Research

Hospitals in Miami produced 13 percent fewer high-quality hospital stays than the U.S. average, while hospitals in Everett, Washington, a city 25 miles north of Seattle, perform over 20 percent better than average on value.

This research was published in Clinical Pharmacology & Therapeutics. The full study can be found here. A press release about the study is here. Citation: Alpert, A., & Jacobson, M. (2019). Impact of Oncology Drug Shortages on Chemotherapy Treatment. Clinical Pharmacology & Therapeutics. Abstract Prescription drug shortages began to increase markedly in the mid‐2000s, including sterile injectable products such […]

Christen Linke Young delivered testimony to the House Education and Labor Subcommittee on Health, Employment, Labor, and Pensions on April 2, 2019.

Using a dynamic microsimulation model to estimate the lifetime burden of serious mental illness for those diagnosed by age twenty-five, the researchers estimated that the per-patient lifetime burden of SMI is $1.85 million.

In this study of patients 65 years and older, short-term postdischarge mortality did not appear to increase for black patients under the HRRP, suggesting that certain value-based payment policies can be implemented without harming black populations. However, mortality seemed to increase for white patients with HF and this situation warrants investigation.

The researchers evaluated the contribution of serious mental illness and specific risk factors (comorbidities and substance use) to the risk of adverse birth outcomes.

Schaeffer Initiative researchers explore why surprise out-of-network billing occurs and how federal and state governments can respond to eliminate these surprise bills and reduce inflated health care costs.

To make greater strides towards value-based payment models in Medicare, Paul Ginsburg recommends that those who are testing alternative payment models at CMS should work directly with the team managing the existing fee-for-service payment system.

Researchers from the USC-Brookings Schaeffer Initiative for Health Policy discuss the negative effects of allowing firms to subsidize the purchase of individual market coverage and why the associated costs are likely to outweigh the benefits to employers and their workers.